Drug-labels.com

Teva-Olopatadine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
0.1 %

Patient Medication Information: uses, side effects, how to take - Teva-Olopatadine

ABOUT THIS MEDICATION

What the medication is used for:

TEVA-OLOPATADINE Solution is used for the prevention and treatment of signs and symptoms of allergic conjunctivitis.

Allergic conjunctivitis: Some materials (allergens) like pollens, house dust or animal fur may cause allergic reactions resulting in itching, redness as well as swelling of the surface of your eye.

What it does:

TEVA-OLOPATADINE Solution is a medicine for treatment and control of allergic conditions of the eye. It works in two different ways by reducing and controlling the intensity of the allergic reaction.

When it should not be used:

TEVA-OLOPATADINE Solution should not be used if you are allergic (hypersensitive) to olopatadine hydrochloride or any of the other ingredients which are listed below. Tell your doctor if you have allergies.

What the medicinal ingredient is:

olopatadine hydrochloride

What the important nonmedicinal ingredients are: Other ingredients include: benzalkonium chloride, sodium chloride, dibasic sodium phosphate, and water for injection. Hydrochloric acid or sodium hydroxide are some times added to maintain proper pH balance.

What dosage forms it comes in:

TEVA-OLOPATADINE Solution is a clear sterile liquid (solution) supplied in a plastic bottle with a screw cap. It is available as 5mL.

WARNINGS AND PRECAUTIONS

This medication must not be taken by mouth.

BEFORE you use TEVA-OLOPATADINE Solution talk to your doctor if:

You have any allergies to TEVA-OLOPATADINE Solution or any of its ingredients or components of the container.

Do not use TEVA-OLOPATADINE Solution in children under the age of three years.

If you wear contact lenses

Do not use the drops while your contact lenses are in your eyes. Wait at least ten minutes after using the eye drops before putting your lenses back into your eyes. A preservative in TEVA-OLOPATADINE Solution (benzalkonium chloride) can affect soft lenses.

Pregnancy or breast-feeding

If you are pregnant, or might get pregnant, talk to your doctor before you use TEVA-OLOPATADINE Solution. If you are breast - feeding, do not use TEVA-OLOPATADINE Solution; it may get into your milk.

Driving and using machines

You may find that your vision is blurred for a time just after you use TEVA-OLOPATADINE Solution. Do not drive or use machines until your vision is clear.

INTERACTION WITH THIS MEDICATION

Please tell your doctor if you are taking or have recently taken any other medicines, even products you have bought yourself without prescription.

PROPER USE OF THIS MEDICATION

Usual dose:

The recommended dose is one to two drops in each affected eye twice daily.

Directions for Use:

  1. 1. Get the bottle of TEVA-OLOPATADINE Solution ready, along with a mirror, if needed.
  2. 2. Wash your hands.
  3. 3. Take the bottle and twist off the cap, being careful not to touch the dropper tip.
  4. 4. Hold the bottle, pointing it down, between your thumb and middle finger.
  5. 5. Tilt your head back and look at the ceiling. Pull down your eyelid with a clean finger, until there is a ‘pocket’ between the eyelid and your eye. The drop will go in there.
  6. 6. Bring the bottle tip close to the eye. Use the mirror if it helps.
  7. 7. Gently press the bottom of the bottle with your forefinger to release one drop at a time. Don’t touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could
IMPORTANT: PLEASE READ

Page 18 infect the drops left in the bottle. Don’t squeeze the bottle: it is designed so that just a gentle press on the bottom is needed.

  1. 8. If you use drops in both eyes, repeat the steps for the other eye.
  2. 9. Put the bottle cap firmly back on immediately after use.

Overdose:

If you get too much in your eyes, rinse it all out with warm water. Don’t put in any more drops until it’s time for your next regular dose. In the event of overdosage, contact your doctor, hospital emergency department or regional Poison Control Centre.

Missed Dose:

If you forget to use TEVA-OLOPATADINE Solution, use a single drop as soon as you remember, and then go back to your regular routine. Do not use a double dose to make up for the one missed.

If you are using other eye drops, wait at least five to ten minutes between putting in TEVA-OLOPATADINE Solution and the other drops.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

A small number of people who use TEVA-OLOPATADINE Solution may get side effects. They can be unpleasant, but most of them disappear rapidly.

You can usually continue using the drops, unless the effects are serious. If you're worried, talk to a doctor or pharmacist.

The most frequent side effect is discomfort in the eye such as burning, stinging, dryness, irritation, swelling and sensitivity to light, or headache. These have been reported by less than one (1) in 100 people.

If you notice any side effects, other than discomfort, please inform your doctor or pharmacist.

HOW TO STORE IT

Store between 4-30°C. Protect from direct sunlight. Discard container at the end of treatment. Keep out of the reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

-------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701E

    Ottawa, Ontario

    K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, Teva Canada Limited at:

1-800-268-4127 ext. 5005 (English);

1-877-777-9117 (French)

or druginfo@tevacanada.com

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

Last revised: January 17, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02312832

Revision date stated in the text: January 17, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Teva-Olopatadine

Rx or OTC
Prescription (Rx)?
DIN 02312832
Schedule(s) PRESCRIPTION
Active ingredient(s) Olopatadine (olopatadine hydrochloride) 0.1 %
Dosage form(s) Solution
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01G Decongestants and antiallergics
        1. S01GX Other antiallergics
          1. S01GX09 Olopatadine
Company TEVA CANADA LIMITED
Current status Cancelled Pre Market
Current status date July 29, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.